Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bank Holiday Ahead Of Q3 Earnings, Trade Negotiations

Published 10/13/2019, 09:58 PM
Updated 07/09/2023, 06:31 AM

Monday, October 14, 2019

In what has been traditionally known throughout the country as Columbus Day (and in many parts of the U.S. being reconsidered as Indigenous Peoples Day), what started out as a 19th century celebration of Italian-American heritage remains a bank holiday in most places this second Monday in October. It has been thus for nearly 50 years.

And, while public schools, post offices, et. al. are closed today, the U.S. stock markets are open for business. We may expect lower trading volume overall today, largely due to the heavy reportage of Q3 earnings beginning promptly tomorrow morning, with major companies like JPMorgan Chase (NYSE:JPM) , Goldman Sachs (NYSE:GS) , Citigroup (NYSE:C) , Johnson & Johnson (NYSE:JNJ) and UnitedHealthcare (NYSE:UNH) all posting new earnings results. There is also no government-based economic data scheduled for today, in observance of the holiday.

Where we see most of the focus in today’s pre-market is in the continuing narrative of a trade truce between the U.S. and China, which on Friday President Trump declared had amounted to a “Phase One agreement.” Since then, however, news reports paint a blurrier picture — with the actual agreement now looking to be signed next month in Santiago, Chile.

This morning on CNBC’s “Squawk Box” program, U.S. Treasury Secretary Steven Mnuchin fielded questions about the trade deal, in which he stated there was “substantial progress” made last week, “subject to documentation,” and that there was still “a lot of work to be done.” This is a clear walk-back from Trump’s earlier announcement of “the greatest and biggest deal ever made for our Great Patriot Farmers in the history of our country.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

What we know now is that tariff hikes planned for this week have been suspended — $250 of Chinese goods imported to the U.S. and $50 billion of agriculture imports from the U.S. to China. Since the trade war began a year ago, however, China has reached agriculture trade deals with countries like Brazil, and any agreement between the U.S. and China would likely not force China to roll back those trade deals.

Among other difficulties will be finding common ground on Intellectual Property (IP) rights, financial services (including currency and foreign exchange considerations) and structural changed in agriculture — all of which Mnuchin said this morning the administration expects to resolve over the next month. On the flip side, an alignment with the needs of state-owned Chinese companies, along with restrictions on free speech regarding China’s ongoing difficulties with protestors in Hong Kong, look to be expected.

For sure, there is still plenty of heavy lifting yet to go in any “Phase One” trade deal. Markets are currently pricing this in, albeit moderately: the Dow is down 60 points at the hour, the Nasdaq down 20 and the S&P 500 down 7.

Mark Vickery

Senior Editor

Questions or comments about this article and/or its author? Click here>>

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See the pot trades we're targeting>>



Citigroup Inc. (C): Free Stock Analysis Report

JPMorgan Chase & Co. (JPM): Free Stock Analysis Report

Johnson & Johnson (JNJ): Free Stock Analysis Report

The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.